Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 -0.26 (-1.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2026)

Updated

Ascentage Pharma Group International's Non-Current Assets was $139.64 million in Q2 2026, down 12.1% from $158.78 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2026) Analysis & Trends

From Q4 2023 onward, Ascentage Pharma Group International has reported Non-Current Assets for 5 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 141.07 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 110.20 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.47 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 34.86 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 159.99 Bn
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn - 139.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.64 Mn
Dec 31, 2025 145.77 Mn
Jun 30, 2025 158.78 Mn
Dec 31, 2024 156.68 Mn
Dec 31, 2023 162.69 Mn
API Access

Ascentage Pharma Group International Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY